Risk Stratification in Pulmonary Arterial Hypertension: Perhaps Simple Is Not Best?
Chest
.
2024 Feb;165(2):431-436.
doi: 10.1016/j.chest.2023.09.005.
Epub 2023 Sep 12.
Authors
Charles Fauvel
1
,
R James White
2
,
Rebecca R Vanderpool
3
,
Roberto Badagliacca
4
,
Tobore Tobore
5
,
Mohammad Rahman
5
,
Carmine Dario Vizza
4
,
Shili Lin
6
,
Allen D Everett
7
,
Scott H Visovatti
3
,
Raymond L Benza
8
Affiliations
1
Department of Cardiology, Normandie University, UNIROUEN, U1096, CHU Rouen, Rouen, France.
2
Department of Pulmonary and Critical Care Medicine, University of Rochester, Rochester, NY.
3
Division of Cardiovascular Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH.
4
Department of Cardiovascular and Respiratory Science, Sapienza University of Rome, Rome, Italy.
5
Actelion Pharmaceuticals US, Inc, Titusville, NY.
6
Department of Statistics, The Ohio State University, Columbus, OH.
7
Department of Pediatric Cardiology, Johns Hopkins University, Baltimore, MD.
8
Department of Cardiology, Mount Sinai Icahn School of Medicine, New York, NY. Electronic address:
[email protected]
.
PMID:
37709252
PMCID:
PMC11075177
DOI:
10.1016/j.chest.2023.09.005
No abstract available
MeSH terms
Familial Primary Pulmonary Hypertension
Humans
Pulmonary Arterial Hypertension*
Risk Assessment